NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 105 filers reported holding NURIX THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 3,422,549 | $90,800,000 | 15.85% |
Ponoi II Management, LLC | 686,274 | $18,207,000 | 14.76% |
Ponoi Management, LLC | 686,274 | $18,207,000 | 10.12% |
Foresite Capital Management V, LLC | 451,522 | $11,979,000 | 4.71% |
Foresite Capital Management IV, LLC | 1,205,798 | $31,990,000 | 4.32% |
Bain Capital Life Sciences Investors, LLC | 1,284,314 | $34,073,000 | 2.23% |
EcoR1 Capital, LLC | 1,967,950 | $52,210,000 | 1.95% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 571,212 | $15,155,000 | 1.93% |
DAFNA Capital Management LLC | 306,320 | $8,127,000 | 1.70% |
Euclidean Capital LLC | 154,426 | $4,097,000 | 1.33% |